As a result, when the Akt activator SC79 was added to baicalin-treated lung cancer cells, the decreased cell proliferation, increased cell cycle arrest, and increased apoptosis were significantly rescued (Figures 4A–C). This evidence concerns the gene AKT1 and lung carcinoma.